Scope Fluidics S.A.

zł 143.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:SCPHealthcare
Country Poland
PE (Fwd) •••
TSR 9Y CAGR 32.61%
Div yield —
ROE (37.96%)
Diagnostics & Research
Beta (5Y) (0.09)
PE TTM —
TSR TTM (5.30%)
Mkt cap zł 453.1M
ROIC (315.19%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 181
26.47%
(79.01%)
Hold 5|0|3|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
3.17
3.05
3.35
3.40
14.59%
(0.65%)
9.99%
6.46%
Revenuezł M
25.73
26.40
27.43
28.45
6.29%
4.09%
9.69%
7.89%
Peers (US$114.4M)
Cap (US$)
PE
400.5M
13.58x
75.84M
—
Capital
TTM
5Y
10Y
Leveragex
4.969
(0.215)
(0.180)
EBIT/Intx
0.711
0.120
0.138
Own earn%
126.16
11.00
15.11
Sh yield%
27.92
22.68
24.93
Owners
Insiders/Inst%
8.99
83.89
Short interest%
2.55
SBC / revenue%
3.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–19
$1 testx
17.7
Incr. ROIC%
0